Ausdal Financial Partners Inc. trimmed its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 16.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,717 shares of the pharmacy operator’s stock after selling 1,740 shares during the quarter. Ausdal Financial Partners Inc.’s holdings in Walgreens Boots Alliance were worth $673,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Hudock Capital Group LLC boosted its holdings in Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after acquiring an additional 6 shares during the period. Modera Wealth Management LLC boosted its stake in shares of Walgreens Boots Alliance by 0.4% in the 1st quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator’s stock valued at $204,000 after buying an additional 9 shares during the period. Flagship Harbor Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 0.5% in the 1st quarter. Flagship Harbor Advisors LLC now owns 3,027 shares of the pharmacy operator’s stock valued at $243,000 after buying an additional 16 shares during the period. Guardian Life Insurance Co. of America boosted its stake in shares of Walgreens Boots Alliance by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 3,301 shares of the pharmacy operator’s stock valued at $274,000 after buying an additional 22 shares during the period. Finally, Northern Capital Management LLC boosted its stake in shares of Walgreens Boots Alliance by 0.4% in the 2nd quarter. Northern Capital Management LLC now owns 6,635 shares of the pharmacy operator’s stock valued at $520,000 after buying an additional 25 shares during the period. Institutional investors own 61.41% of the company’s stock.

Several equities analysts have recently issued reports on WBA shares. UBS reiterated a “buy” rating and issued a $96.00 price objective (down previously from $97.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, August 23rd. Loop Capital started coverage on Walgreens Boots Alliance in a research note on Thursday, August 24th. They issued a “buy” rating and a $95.00 price objective for the company. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, August 30th. Jefferies Group reiterated a “buy” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, September 7th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Sunday, September 10th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Walgreens Boots Alliance has a consensus rating of “Buy” and an average target price of $86.47.

In other news, Director John Anthony Lederer purchased 20,000 shares of the business’s stock in a transaction on Thursday, October 26th. The shares were bought at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the transaction, the director now directly owns 50,000 shares in the company, valued at approximately $3,350,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now directly owns 16,415 shares in the company, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. 14.80% of the stock is currently owned by company insiders.

Shares of Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $71.94 on Monday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07. Walgreens Boots Alliance Inc has a 12-month low of $63.82 and a 12-month high of $88.00. The firm has a market capitalization of $71,246.21, a PE ratio of 14.11, a PEG ratio of 1.28 and a beta of 1.22.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The business had revenue of $30.15 billion for the quarter, compared to analyst estimates of $29.93 billion. During the same quarter last year, the company earned $1.07 EPS. The business’s quarterly revenue was up 5.3% on a year-over-year basis. research analysts forecast that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th were given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.22%. The ex-dividend date of this dividend was Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 42.33%.

Walgreens Boots Alliance declared that its board has approved a stock repurchase program on Wednesday, October 25th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.

COPYRIGHT VIOLATION WARNING: “Walgreens Boots Alliance Inc (WBA) Position Lessened by Ausdal Financial Partners Inc.” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another site, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this article can be read at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-position-lessened-by-ausdal-financial-partners-inc/1770814.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.